Medicare Enrolled

Dr. Chirag Jhaveri, M.D.

Ophthalmology · Austin, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
3705 MEDICAL PKWY STE 460, Austin, TX 78705
5124545851
In practice since 2007 (18 years)
NPI: 1114117769 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jhaveri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jhaveri? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jhaveri

Dr. Chirag Jhaveri is an ophthalmology in Austin, TX, with 18 years in practice. Based on federal Medicare data, Dr. Jhaveri performed 25,353 Medicare services across 2,483 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jhaveri received a total of $192,551 from 30 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jhaveri is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 4% volume in TX$ $192,551 industry payments

Medicare Practice Summary

Medicare Utilization ↗
25,353
Medicare services
Top 4% in TX for ophthalmology
2,483
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,408 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)20,160$29$110
Retinal imaging (OCT scan)1,362$29$90
Comprehensive eye exam, established patient974$89$173
Extended exam of the back part of the eye with retinal drawing955$18$66
Eye injection for retinal disease646$97$300
Aflibercept eye injection (Eylea)588$673$2,000
Office visit, established patient (20-29 min)169$68$115
New patient office visit (45-59 min)98$117$252
Unclassified drugs93$3,129$7,403
Retinal photography (fundus photo)86$27$156
Injection, bevacizumab, 10 mg51$54$260
Eye exam, established patient, focused45$66$190
Office visit, established patient (30-39 min)41$70$157
Exam of retinal blood vessels using a special camera after injection of a dye32$107$263
New patient office visit, complex (60-74 min)29$140$309
Photocoagulation treatment to prevent detachment of retina12$189$785
Office visit, established patient, complex (40-54 min)12$132$220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$192,551
Total received (2018-2024)
Avg $27,507/year across 7 years
Top 2% in TX for ophthalmology
30
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$156,579 (81.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$32,038 (16.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,934 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$60,517
2023
$36,882
2022
$35,430
2021
$1,766
2020
$9,927
2019
$45,288
2018
$2,740

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$60,936
Novartis Pharmaceuticals Corporation
$44,035
Genentech USA, Inc.
$27,748
Regeneron Healthcare Solutions, Inc.
$18,922
Boehringer Ingelheim International GmbH
$13,695
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,371
Regeneron Pharmaceuticals, Inc.
$4,649
ABBVIE INC.
$2,924
Allergan Inc.
$2,761
F. Hoffmann-La Roche AG
$2,700
Genentech, Inc.
$2,499
GlaxoSmithKline, LLC.
$2,220
Alimera Sciences, Inc.
$1,320
EyePoint Pharmaceuticals US, Inc.
$367
TissueTech, Inc.
$304
Ocular Therapeutix, Inc.
$241
Optos, Inc.
$156
Apellis Pharmaceuticals, Inc.
$139
Merz North America, Inc.
$136
Johnson & Johnson Surgical Vision, Inc.
$109
Hoffmann-La Roche Limited
$70
Allergan, Inc.
$65
Harrow Eye, LLC
$36
Biogen, Inc.
$35
Alcon Vision LLC
$30
AbbVie, Inc.
$23
Carl Zeiss Meditec AG
$19
Coherus Biosciences Inc.
$17
Bausch & Lomb, a division of Bausch Health US, LLC
$13
Spark Therapeutics, Inc.
$11
Top 3 companies account for 68.9% of total payments
Associated products mentioned in payments ›
BEOVU · BROLUCIZUMAB · BUPARLISIB · Cimerli · Constellation · DEXTENZA · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · IHEEZO · Iluvien · Izervay · LUXTURNA · Lucentis · Non-Covered Product · None Specified · OZURDEX · P200DTx · PANORAMIC OPHTHALMOSCOPE · Prokera · RTH258B · SUSVIMO · Susvimo · Syfovre · VABYSMO · VISUDYNE · Vabysmo · XEOMIN · XIIDRA · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for ophthalmology in TX.

Equivalent to $759 per 100 Medicare services performed
Looking for a ophthalmology in Austin?
Compare ophthalmologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
133
Per 100K population
10.2
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jhaveri is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jhaveri experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Jhaveri performed 20,160 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jhaveri receive payments from pharmaceutical companies?
Yes. Dr. Jhaveri received a total of $192,551 from 30 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jhaveri's costs compare to other ophthalmologys in Austin?
Dr. Jhaveri's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jhaveri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →